{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:14:53Z","timestamp":1791270893475,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.neurol.2011.07.007","type":"journal-article","created":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T15:45:36Z","timestamp":1314978336000},"page":"691-698","source":"Crossref","is-referenced-by-count":6,"title":["\u00ab\u00a0OMICS\u00a0\u00bb et biomarqueurs dans les tumeurs gliales"],"prefix":"10.1016","volume":"167","author":[{"given":"A.","family":"Idbaih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2011.07.007_bib0005","doi-asserted-by":"crossref","first-page":"e4107","DOI":"10.1371\/journal.pone.0004107","article-title":"NOTCH2\u00a0is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas","volume":"4","author":"Benetkiewicz","year":"2009","journal-title":"PLoS One."},{"key":"10.1016\/j.neurol.2011.07.007_bib0010","doi-asserted-by":"crossref","first-page":"e7752","DOI":"10.1371\/journal.pone.0007752","article-title":"Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations","volume":"4","author":"Brennan","year":"2009","journal-title":"PLoS One."},{"key":"10.1016\/j.neurol.2011.07.007_bib0015","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","article-title":"Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas","volume":"90","author":"Cairncross","year":"1998","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.neurol.2011.07.007_bib0020","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"Cancer Genome Atlas Research Network","year":"2008","journal-title":"Nature."},{"key":"10.1016\/j.neurol.2011.07.007_bib0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00401-011-0817-z","article-title":"Oncogenic FAM131B-BRAF fusion resulting from 7q34\u00a0deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma","volume":"121","author":"Cin","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0030","doi-asserted-by":"crossref","first-page":"e17948","DOI":"10.1371\/journal.pone.0017948","article-title":"BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications","volume":"6","author":"Dias-Santagata","year":"2011","journal-title":"PLoS One."},{"key":"10.1016\/j.neurol.2011.07.007_bib0035","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/01.jnen.0000235122.98052.8f","article-title":"Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss","volume":"65","author":"Griffin","year":"2006","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.coph.2008.06.014","article-title":"Therapeutic strategies for inhibiting oncogenic BRAF signaling","volume":"8","author":"Halilovic","year":"2008","journal-title":"Curr Opin Pharmacol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0045","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1158\/1078-0432.CCR-11-0034","article-title":"BRAF-KIAA1549\u00a0Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma","volume":"17","author":"Hawkins","year":"2011","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.neurol.2011.07.007_bib0050","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.neurol.2011.07.007_bib0055","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ana.20607","article-title":"Two types of chromosome 1p losses with opposite significance in gliomas","volume":"58","author":"Idbaih","year":"2005","journal-title":"Ann Neurol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0060","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","article-title":"A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma","volume":"66","author":"Jenkins","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.neurol.2011.07.007_bib0065","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","article-title":"Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas","volume":"68","author":"Jones","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.neurol.2011.07.007_bib0070","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","article-title":"Radiotherapy for glioblastoma in the elderly","volume":"356","author":"Keime-Guibert","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.neurol.2011.07.007_bib0200","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2011.07.007_bib0075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2174\/156800910793357970","article-title":"Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas","volume":"10","author":"Lo","year":"2010","journal-title":"Curr Cancer Drug Targets."},{"key":"10.1016\/j.neurol.2011.07.007_bib0080","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0002-9440(10)61750-6","article-title":"Glioma classification: a molecular reappraisal","volume":"159","author":"Louis","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neurol.2011.07.007_bib0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007\u00a0WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0090","doi-asserted-by":"crossref","first-page":"11502","DOI":"10.1158\/0008-5472.CAN-06-2072","article-title":"Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities","volume":"66","author":"Maher","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.neurol.2011.07.007_bib0095","first-page":"239","article-title":"Ras oncogene mutations in childhood brain tumors","volume":"6","author":"Maltzman","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/j.neurol.2011.07.007_bib0100","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell."},{"key":"10.1016\/j.neurol.2011.07.007_bib0105","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/WCO.0b013e3283405b5f","article-title":"Nervous system tumors associated with familial tumor syndromes","volume":"23","author":"Ohgaki","year":"2010","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0110","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science."},{"key":"10.1016\/j.neurol.2011.07.007_bib0115","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI33656","article-title":"BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas","volume":"118","author":"Pfister","year":"2008","journal-title":"J Clin Invest."},{"key":"10.1016\/j.neurol.2011.07.007_bib0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/cbt.8.1.7237","article-title":"Pediatric low-grade gliomas and the need for new options for therapy: why and how?","volume":"8","author":"Qaddoumi","year":"2009","journal-title":"Cancer Biol Ther."},{"key":"10.1016\/j.neurol.2011.07.007_bib0125","first-page":"1175","article-title":"Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p","volume":"145","author":"Reifenberger","year":"1994","journal-title":"Am J Pathol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0130","doi-asserted-by":"crossref","DOI":"10.1111\/j.1750-3639.2011.00491.x","article-title":"French Brain Tumor DataBase (FBTDB): 5-year histological results on 25\u00a0756\u00a0cases","author":"Rigau","year":"2011","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neurol.2011.07.007_bib0135","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2009.21.9832","article-title":"Isocitrate dehydrogenase 1\u00a0codon 132\u00a0mutation is an important prognostic biomarker in gliomas","volume":"27","author":"Sanson","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","article-title":"Analysis of BRAF V600E mutation in 1,320\u00a0nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma","volume":"121","author":"Schindler","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0145","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ng.407","article-title":"Genome-wide association study identifies five susceptibility loci for glioma","volume":"41","author":"Shete","year":"2009","journal-title":"Nat Genet."},{"key":"10.1016\/j.neurol.2011.07.007_bib0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.2000.18.3.636","article-title":"Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0155","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.neurol.2011.07.007_bib0205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jocn.2003.04.003","article-title":"Pleomorphic xanthoastrocytoma: report of two cases and review of the prognostic factors","volume":"11","author":"Tan","year":"2004","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.neurol.2011.07.007_bib0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jcp.21978","article-title":"MAPK pathway activation and the origins of pediatric low-grade astrocytomas","volume":"222","author":"Tatevossian","year":"2010","journal-title":"J Cell Physiol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00401-010-0725-7","article-title":"Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective","volume":"120","author":"van den Bent","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurol.2011.07.007_bib0210","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1200\/JCO.2005.04.6078","volume":"24","author":"van den Bent","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neurol.2011.07.007_bib0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell."},{"key":"10.1016\/j.neurol.2011.07.007_bib0180","doi-asserted-by":"crossref","first-page":"552","DOI":"10.18632\/oncotarget.190","article-title":"Targeting metabolic remodeling in glioblastoma multiforme","volume":"1","author":"Wolf","year":"2010","journal-title":"Oncotarget."},{"key":"10.1016\/j.neurol.2011.07.007_bib0185","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ng.408","article-title":"Variants in the CDKN2B and RTEL1\u00a0regions are associated with high-grade glioma susceptibility","volume":"41","author":"Wrensch","year":"2009","journal-title":"Nat Genet."},{"key":"10.1016\/j.neurol.2011.07.007_bib0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell."},{"key":"10.1016\/j.neurol.2011.07.007_bib0195","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1\u00a0and IDH2\u00a0mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med."}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711003067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711003067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T22:19:14Z","timestamp":1712787554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378711003067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0035378711003067"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2011.07.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}